Future Oncology at a glance: a spotlight on lung cancer

Discover a curated selection of lung cancer articles published in Future Oncology in this 2025 roundup, which highlights key content pieces and their potential clinical impact. The value of real-world evidence in supporting targeted therapies for patients with rare oncogenic drivers in mNSCLC Metastatic NSCLC treatment has become increasingly personalized with targeted therapies for specific oncogenic drivers. For rare drivers with small patient populations, randomized controlled trials face enrolment obstacles as well as patient representation and duration challenges. In this White Paper, the authors detail the potential of real-world evidence in enhancing randomized controlled trials to better inform treatment decision...